Indoco Remedies Limited (INDOCO)
ISIN: INE873D01024 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
364.25
-5.9(-1.59%)

Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren – S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

369.85

TODAY'S LOW

356

52 WEEK HIGH

530.25

52 WEEK LOW

322.7

Major Holders

% of Shares Held by
All Insider

60.06%

% of Shares Held by
Institutions

17.82%

% of Float Held by
Institutions

44.61%

Number of Institutions
Holding Shares

22

Company Overview

MARKET CAP

3368.36 Cr.

ETERPRISE VALUE

3647.48 Cr.

NO. OF SHARES

9.21 Cr.

BOOK VALUE

98.18

DIV. YIELD

1.5%

DEBT

256.65 Cr.

GROSS PROFIT

1086.29 Cr.

CASH

19.78 Cr.

REVENUE

1543.08 Cr.

REVENUE/SHARE

167.466

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments000-11.12 Lakhs
Change To Liabilities21.43 Cr.-50.70 Cr.-5.04 Cr.22.27 Cr.
Total cashflows from Investing Activities-121.41 Cr.-66.69 Cr.-55.93 Cr.-103.75 Cr.
Net Borrowings-15.59 Cr.-3.88 Cr.-38.25 Cr.15.76 Cr.
Total Cash from Financing Activities-44.37 Cr.-29.87 Cr.-63.94 Cr.-16.14 Cr.
Other Liabilities1.21 Cr.-19.29 Cr.46.26 Cr.9.14 Cr.
Total Assets0000
Net Income154.80 Cr.93.04 Cr.24.11 Cr.-2.90 Cr.
Change in Cash8.05 Cr.-14.34 Cr.2.96 Cr.12.21 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities173.83 Cr.82.22 Cr.122.84 Cr.132.11 Cr.
Depreciation78.96 Cr.49.78 Cr.47.75 Cr.41.89 Cr.
Other Cashflows from Investing Activities2.97 Cr.9.95 Cr.2.43 Cr.-10.64 Cr.
Dividends Paid-13.79 Cr.-2.78 Cr.-3.36 Cr.-11.09 Cr.
Change to Inventory-72.66 Cr.-29.53 Cr.-24.86 Cr.9.93 Cr.
Change to Account Receivables-58.78 Cr.-40.27 Cr.-17.84 Cr.14.26 Cr.
Other Cashflows from Financing Activities-14.99 Cr.-23.20 Cr.-22.33 Cr.-20.81 Cr.
Change to Net Income48.87 Cr.55.86 Cr.32.26 Cr.7.83 Cr.
Capital Expenditures-125.32 Cr.-76.84 Cr.-58.46 Cr.-96.94 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research Development74.64 Cr.59.70 Cr.49.70 Cr.51.51 Cr.
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax236.57 Cr.131.99 Cr.28.57 Cr.-9.31 Cr.
Minority InterestNoneNoneNoneNone
Net Income250.71 Cr.153.08 Cr.55.59 Cr.6.68 Cr.
Selling General Administrative293.70 Cr.317.57 Cr.308.65 Cr.271.58 Cr.
Gross Profit1086.29 Cr.857.35 Cr.746.64 Cr.621.44 Cr.
Ebit250.71 Cr.153.08 Cr.55.59 Cr.6.68 Cr.
Operating Income250.71 Cr.153.08 Cr.55.59 Cr.6.68 Cr.
Other Operating Expenses388.28 Cr.237.34 Cr.256.73 Cr.219.58 Cr.
Interest Expense-14.14 Cr.-21.04 Cr.-22.30 Cr.-19.96 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense81.77 Cr.38.95 Cr.4.45 Cr.-6.40 Cr.
Total Revenue1543.08 Cr.1241.52 Cr.1106.58 Cr.968.44 Cr.
Total Operating Expenses1292.37 Cr.1088.44 Cr.1050.99 Cr.961.76 Cr.
Cost of Revenue456.79 Cr.384.17 Cr.359.93 Cr.347 Cr.
Total Other Income Expense Net-14.14 Cr.-21.08 Cr.-27.01 Cr.-15.99 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.154.80 Cr.93.04 Cr.24.11 Cr.-2.90 Cr.
Net Income Applicable to Common Shares154.80 Cr.93.04 Cr.24.11 Cr.-2.90 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets91.88 Cr.84.51 Cr.91.40 Cr.95.14 Cr.
Capital Surplus064.20 Cr.64.20 Cr.64.20 Cr.
Total Liabilities581.45 Cr.546.07 Cr.592.02 Cr.597.42 Cr.
Stock Holder Equity904.64 Cr.768.99 Cr.679.56 Cr.660.62 Cr.
Minority Interest0000
Other Liabilities141.75 Cr.104.30 Cr.98.64 Cr.79.83 Cr.
Total Assets1486.09 Cr.1315.06 Cr.1271.59 Cr.1258.04 Cr.
Common Stock18.43 Cr.18.43 Cr.18.43 Cr.18.43 Cr.
Retained Earnings0686.35 Cr.596.92 Cr.577.98 Cr.
Other Liabilities49.75 Cr.35.20 Cr.30.61 Cr.23.26 Cr.
Good Will9 Lakhs9 Lakhs9 Lakhs9 Lakhs
Treasury Stock886.21 Cr.2 k2 k2 k
Other Assets35.82 Cr.54.38 Cr.68.02 Cr.66.89 Cr.
Cash19.78 Cr.9.41 Cr.23.76 Cr.20.79 Cr.
Current Liabilities424.86 Cr.406.91 Cr.458.98 Cr.445.50 Cr.
Long Term Asset Charges019.35 Cr.35.90 Cr.35.50 Cr.
Short Long Term Debt044.94 Cr.58.80 Cr.54.25 Cr.
Other Stockholder Equity886.21 Cr.2 k2 k2 k
Property Plant Equipment584.66 Cr.553.53 Cr.548.94 Cr.557.84 Cr.
Total Cur. Assets773.62 Cr.622.52 Cr.563.10 Cr.538.05 Cr.
Long Term Investments2 Lakhs2.10 Lakhs2.10 Lakhs2.10 Lakhs
Net Tangible Assets812.67 Cr.684.38 Cr.588.07 Cr.565.38 Cr.
Short Term Investments0000
Net Receivables297.78 Cr.235.38 Cr.211.28 Cr.196.48 Cr.
Long Term Debt95.88 Cr.96.93 Cr.96.93 Cr.128.65 Cr.
Inventory310.52 Cr.237.85 Cr.208.31 Cr.183.45 Cr.
Accounts Payable133.29 Cr.113.22 Cr.165.60 Cr.170.72 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account